People · Operator
Named in public records as an officer, director or promoter · active 2008–2022 · Pharmaceuticals, Other Health Care, Other Technology, Software / Tech, Manufacturing
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Collegium Pharmaceutical, Inc | — | Pharmaceuticals | Series C | $97.5M | $701.8M | 2015 |
| Calypso Medical Technologies Inc | — | Other Health Care | Series C | $69.5M | $171.5M | 2009 |
| Satiety Inc | — | Other Health Care | Series B | $34.3M | $559.9M | 2009 |
| Discoverx Corp | — | Other Technology | Series A | $13.6M | $221.9M | 2008 |
| Medivance Inc | — | Other Health Care | Series A | $8.1M | $162.8M | 2009 |
| Jump Technologies, Inc. | — | Software / Tech | Seed | $7.2M | $16.8M | 2016 |
| SCG Jet Edge Holdings Limited Partnership | — | Manufacturing | Series A | $6.0M | $54.8M | 2020 |
John Freund at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside John Freund on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| David Hirsch | 1 | 16 |
| Patrick Heron | 1 | 11 |
| David Gill | 1 | 8 |
| Alan Levy | 1 | 7 |
| Stephen Hoffman | 1 | 7 |
| Ross Jaffe | 1 | 7 |
| Henry A. Plain, Jr. | 1 | 7 |
| Jeanne Cunicelli | 1 | 7 |
| Michael Sweeney | 1 | 7 |
| Melissa Daniels | 1 | 6 |
| Noah Kroloff | 1 | 6 |
| Robert Kline | 1 | 6 |
| Alan Frazier | 1 | 5 |
| Michael Heffernan | 1 | 5 |
| Gino Santini | 1 | 5 |
| Paul Brannelly | 1 | 4 |
| Richard Johnston | 1 | 4 |
| Esfandiar Lohrasbpour | 1 | 4 |
| Eran Nadav | 1 | 4 |
| Daniel Janney | 1 | 3 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.